← back to search

Mark P. Mattson

Johns Hopkins University · US
Area of research
Physiology · Cellular and Molecular Neuroscience
Research interest
Research interests include Alzheimer's disease research and treatments, Neuroscience and Neuropharmacology Research, Neuroinflammation and Neurodegeneration Mechanisms, and Mitochondrial Function and Pathology.
h-index
218
citations
172,835
works
1,286
NIH funding
primary concept
email

Recent publications

International consensus on fasting terminology
Cell Metabolism 2024cited by 87position: middledoi
Time-Restricted Feeding Reduces Atherosclerosis in LDLR KO Mice but Not in ApoE Knockout Mice
Arteriosclerosis Thrombosis and Vascular Biology 2024cited by 13position: middledoi
Common and divergent molecular mechanisms of fasting and ketogenic diets
Trends in Endocrinology and Metabolism 2023cited by 46position: middledoi
Defining Prolonged and Intermittent Fasting: International Consensus on Fasting Terminology
SSRN Electronic Journal 2023cited by 2position: middledoi
NAD <sup>+</sup> supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer’s disease via cGAS–STING
Proceedings of the National Academy of Sciences 2021cited by 493position: middledoi
Intermittent and periodic fasting, longevity and disease
Nature Aging 2021cited by 260position: middledoi
Glucose metabolic crosstalk and regulation in brain function and diseases
Progress in Neurobiology 2021cited by 191position: middledoi
TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration
Nature Neuroscience 2021cited by 162position: middledoi
Neuronal and Astrocytic Extracellular Vesicle Biomarkers in Blood Reflect Brain Pathology in Mouse Models of Alzheimer’s Disease
Cells 2021cited by 76position: middledoi
Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
Nature Reviews Drug Discovery 2020cited by 959position: middledoi
Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease
Neurobiology of Disease 2020cited by 184position: lastdoi
Astrocyte- and Neuron-Derived Extracellular Vesicles from Alzheimer’s Disease Patients Effect Complement-Mediated Neurotoxicity
Cells 2020cited by 96position: middledoi
Topoisomerase 3β knockout mice show transcriptional and behavioural impairments associated with neurogenesis and synaptic plasticity
Nature Communications 2020cited by 37position: middledoi
Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease
Nature Neuroscience 2019cited by 1,663position: middledoi
Effects of Intermittent Fasting on Health, Aging, and Disease
New England Journal of Medicine 2019cited by 1,519position: lastdoi
Senolytic therapy alleviates Aβ-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer’s disease model
Nature Neuroscience 2019cited by 945position: lastdoi
NAD+ in Brain Aging and Neurodegenerative Disorders
Cell Metabolism 2019cited by 744position: middledoi
NAD+ augmentation restores mitophagy and limits accelerated aging in Werner syndrome
Nature Communications 2019cited by 269position: middledoi
NRF2/ARE pathway negatively regulates BACE1 expression and ameliorates cognitive deficits in mouse Alzheimer’s models
Proceedings of the National Academy of Sciences 2019cited by 203position: middledoi
SIRT3 mediates hippocampal synaptic adaptations to intermittent fasting and ameliorates deficits in APP mutant mice
Nature Communications 2019cited by 168position: lastdoi
Chronic Mild Gut Inflammation Accelerates Brain Neuropathology and Motor Dysfunction in α-Synuclein Mutant Mice
NeuroMolecular Medicine 2019cited by 134position: lastdoi
Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States
Cell Metabolism 2018cited by 1,197position: firstdoi
Intermittent metabolic switching, neuroplasticity and brain health
Nature reviews. Neuroscience 2018cited by 587position: firstdoi
NAD <sup>+</sup> supplementation normalizes key Alzheimer’s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency
Proceedings of the National Academy of Sciences 2018cited by 457position: middledoi
Effect of intermittent vs. daily calorie restriction on changes in weight and patient-reported outcomes in people with multiple sclerosis
Multiple Sclerosis and Related Disorders 2018cited by 149position: middledoi
Notch signaling and neuronal death in stroke
Progress in Neurobiology 2018cited by 142position: middledoi
Enhancing and Extending Biological Performance and Resilience
Dose-Response 2018cited by 104position: middledoi
Mitophagy and Alzheimer’s Disease: Cellular and Molecular Mechanisms
Trends in Neurosciences 2017cited by 861position: middledoi
Flipping the Metabolic Switch: Understanding and Applying the Health Benefits of Fasting
Obesity 2017cited by 746position: lastdoi
Brain metabolism in health, aging, and neurodegeneration
The EMBO Journal 2017cited by 736position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Vilhelm A. Bohr · University of Copenhagen10 papers (2014–2021)Thiruma V. Arumugam · National University of Singapore8 papers (2012–2019)Deborah L. Croteau · National Human Genome Research Institute7 papers (2014–2021)Dong‐Gyu Jo · Johns Hopkins Medicine7 papers (2013–2019)Evandro Fei Fang · Norwegian Institute of Public Health7 papers (2014–2019)Krisztina Marosi · UCLA Health7 papers (2013–2017) · 6 papers (2013–2017)Dimitrios Kapogiannis · Institute on Aging6 papers (2013–2021) · 5 papers (2012–2019)Sofie Lautrup · University of Oslo5 papers (2017–2021)Rafael de Cabo · National Institutes of Health5 papers (2014–2019)Yong Liu · Second Affiliated Hospital of Guangzhou Medical University4 papers (2015–2021) · 4 papers (2017–2021) · 4 papers (2013–2024) · 4 papers (2012–2013)Morten Scheibye‐Knudsen · University of Copenhagen4 papers (2014–2016)Valter D. Longo · University of Southern California4 papers (2014–2021)David Y. Fann · National University of Singapore3 papers (2013–2014)Victoria C. Cogger · Anzac Research Institute3 papers (2014–2017) · 3 papers (2012–2019)